Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
NCT01052480
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
98
Enrollment
NIH
Sponsor class
Conditions
Influenza A
Influenza B
Interventions
BIOLOGICAL:
Anti-Influenza Immune Plasma
DRUG:
Standard Care
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)